Allurion Technologies Inc. (ALUR) garnered renewed optimism from analysts this week, earning a “Buy” rating from Keay Nakae of Chardan Capital on February 24, 2026. With a current trading price of $1.36 and a targeted price of $3, this latest endorsement highlights potential upside and positions investors to consider the implications of both risk and opportunity within the context of the company’s evolving financial landscape.
Recent Price Action
In the wake of Chardan Capital’s bullish outlook, ALUR’s stock has experienced significant volatility. Trading at $1.36, the stock has seen a loss of $0.39—or approximately 22.3%—over recent sessions. With a market capitalization of roughly $10.56 million, this stock has experienced a staggering decline of 67.5% from its 52-week high, while also remaining far below its 52-week low of $43.16. Volume has surged substantially, with over 13 million shares traded, well above its average volume of about 980,000. This surge in activity suggests heightened investor interest, albeit amid a backdrop of noteworthy volatility, reflected by a beta of -0.469, indicating a generally defensive position relative to broader market fluctuations.
Short- and Long-Term Performance
Analyzing ALUR’s performance over varying timeframes offers insight into its trajectory. The stock has experienced a solid 30-day performance of 6.67%, contrasting sharply with a quarterly decline of 19.4% and an alarming drop of 48.72% over the past year. Weekly volatility stands at 9.2%, while monthly volatility is noted at 10.21%. These figures may reflect broader market pressures, but the recent uptick over the last month may indicate emerging investor confidence amid the analyst upgrade.
Earnings Analysis
In its latest earnings report released on November 12, 2025, Allurion reported earnings per share (EPS) of -$1.18, a slight improvement against estimates of -$1.30, showcasing a surprise factor of approximately 9.2%. This contrasts with the previous quarter, where the company posted an EPS of -$0.57—better than the -$0.65 expected. Despite ongoing losses, these deviations from estimates could suggest a level of operational stability that investors may find encouraging, albeit in the context of a challenging financial environment.
Analyst / Consensus View
From a consensus perspective, Allurion Technologies holds a cautious but positive outlook. The stock has received one rating, all of which label it a “Buy,” with an average price target matching Chardan Capital’s set target of $3. The absence of hold or sell ratings further emphasizes a clear, albeit nascent, bullish sentiment among analysts. This singular bullish perspective indicates that while the consensus remains thin, it reflects a growing belief in Allurion’s potential recovery and value realization.
Stock Grading or Fundamental View
According to the Stocks Telegraph grading system, Allurion’s ST Score currently sits at 42, indicating moderate confidence in its overall health and investment profile. While the score cannot be classified as exceptional, it highlights underlying financial metrics that, when coupled with recent analyst upgrades, suggest an investment profile worthy of attention.
Conclusion
Allurion Technologies Inc. represents an intriguing opportunity for investors willing to embrace risk in pursuit of potential rewards. With its current valuation, low stock price, and emerging analyst support, the stock may attract long-term investors seeking growth stemming from underappreciated assets. However, the risks remain tangible, especially in light of historical stock performance and the company’s ongoing battle to achieve profitability. As the market watches closely for signs of operational improvements amidst a strategic pivot, ALUR stands as a stock to keep on the radar for those with a higher risk tolerance who are poised to capitalize on long-term recovery scenarios.